KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2018 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Prepaid Assets for 7 consecutive years, with $6.6 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Prepaid Assets fell 5.71% year-over-year to $6.6 million, compared with a TTM value of $6.6 million through Jun 2025, down 5.71%, and an annual FY2024 reading of $1.1 million, down 88.1% over the prior year.
  • Prepaid Assets was $6.6 million for Q2 2025 at Aurinia Pharmaceuticals, up from $781000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $16.2 million in Q3 2023 and bottomed at $781000.0 in Q1 2025.
  • Average Prepaid Assets over 5 years is $6.9 million, with a median of $7.3 million recorded in 2024.
  • The sharpest move saw Prepaid Assets surged 611.09% in 2023, then plummeted 89.79% in 2025.
  • Year by year, Prepaid Assets stood at $11.7 million in 2021, then crashed by 88.61% to $1.3 million in 2022, then soared by 611.09% to $9.5 million in 2023, then crashed by 88.1% to $1.1 million in 2024, then skyrocketed by 482.64% to $6.6 million in 2025.
  • Business Quant data shows Prepaid Assets for AUPH at $6.6 million in Q2 2025, $781000.0 in Q1 2025, and $1.1 million in Q4 2024.